MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 06.11.2025
ClearPoint Neuro Betriebsaufwand 2011-2026 | CLPT
Betriebsaufwand Jährlich ClearPoint Neuro
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 15.3 M | 12 M | 10.2 M | 10.8 M | 10.6 M | 10.3 M | 11.3 M | 9.98 M | 7.63 M | 9.08 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 15.3 M | 7.63 M | 10.7 M |
Betriebsaufwand anderer Aktien in der Medizinische Geräte
| Name | Betriebsaufwand | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
8.59 M | - | -26.83 % | $ 2.62 M |  USA |
 |
Alphatec Holdings
ATEC
|
614 M | $ 13.84 | -1.46 % | $ 2.08 B | USA |
 |
Allied Healthcare Products
AHPI
|
7.81 M | - | 3.58 % | $ 2.21 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
79 M | - | - | $ 1.77 B | USA |
 |
Apollo Endosurgery
APEN
|
73.8 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
18.6 M | - | -20.74 % | $ 369 K | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
11.2 M | - | -5.86 % | $ 30.6 M | USA |
 |
AxoGen
AXGN
|
121 M | $ 31.73 | 1.63 % | $ 1.46 B | USA |
 |
Cognyte Software Ltd.
CGNT
|
293 M | $ 6.93 | 4.62 % | $ 498 M |  Israel |
 |
EDAP TMS S.A.
EDAP
|
20.8 M | $ 4.55 | -0.78 % | $ 170 M |  France |
 |
Axonics Modulation Technologies
AXNX
|
263 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
41.6 M | - | 1.37 % | $ 20.5 M | USA |
 |
Apyx Medical Corporation
APYX
|
53.7 M | $ 3.43 | 0.3 % | $ 119 M | USA |
 |
Conformis
CFMS
|
69.5 M | - | - | $ 16.4 M | USA |
 |
Electromed
ELMD
|
40.3 M | $ 24.42 | 2.73 % | $ 206 M | USA |
 |
Bio-Rad Laboratories
BIO
|
1.03 B | $ 273.54 | 1.52 % | $ 7.72 B | USA |
 |
BIOLASE
BIOL
|
34.7 M | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
1.4 B | $ 41.3 | 3.52 % | $ 6.15 K | USA |
 |
BioSig Technologies
BSGM
|
12.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
10.2 B | $ 75.47 | 2.72 % | $ 112 B | USA |
 |
InMode Ltd.
INMD
|
136 M | $ 14.01 | 0.36 % | $ 906 M | Israel |
 |
IRIDEX Corporation
IRIX
|
31.8 M | $ 1.47 | -2.0 % | $ 23.7 M | USA |
 |
IRadimed Corporation
IRMD
|
34.4 M | $ 102.68 | 2.17 % | $ 1.3 B | USA |
 |
CryoLife, Inc.
CRY
|
165 M | - | -4.14 % | $ 702 M | USA |
 |
CONMED Corporation
CNMD
|
648 M | $ 46.15 | 0.39 % | $ 1.43 B | USA |
 |
Soliton, Inc.
SOLY
|
14.4 M | - | -1.42 % | $ 435 M | USA |
 |
Cardiovascular Systems
CSII
|
209 M | - | 0.15 % | $ 844 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.14 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
39.1 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
63.1 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
36.4 M | - | - | $ 111 M |  Canada |
 |
LivaNova PLC
LIVN
|
697 M | $ 71.34 | 1.49 % | $ 3.89 B |  Britain |
 |
Cutera
CUTR
|
198 M | - | -10.19 % | $ 1.99 M | USA |
 |
Medtronic PLC
MDT
|
15.3 B | $ 97.34 | 0.7 % | $ 125 B | USA |
 |
MiMedx Group
MDXG
|
277 M | $ 5.1 | -3.41 % | $ 754 M | USA |
 |
Delcath Systems
DCTH
|
43.4 M | $ 9.16 | -10.28 % | $ 261 M | USA |
 |
Intersect ENT, Inc.
XENT
|
118 M | - | - | $ 955 M | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
60 M | $ 2.47 | 0.9 % | $ 145 M | Israel |
 |
Dynatronics Corporation
DYNT
|
18.1 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
126 M | - | - | $ 10.2 M | USA |
 |
Second Sight Medical Products
EYES
|
24.7 M | - | -0.97 % | $ 54.4 M | USA |
 |
Establishment Labs Holdings
ESTA
|
160 M | $ 76.21 | -2.66 % | $ 2.15 B |  Costa-rica |
 |
Insulet Corporation
PODD
|
531 M | $ 251.87 | 1.51 % | $ 17.7 B | USA |
 |
GBS
GBS
|
12.7 M | - | -0.57 % | $ 7.12 M | USA |
 |
Quanterix Corporation
QTRX
|
120 M | $ 6.57 | 4.45 % | $ 247 M | USA |
 |
FONAR Corporation
FONR
|
28.7 M | $ 18.53 | -0.27 % | $ 121 M | USA |
 |
Sintx Technologies
SINT
|
15.2 M | $ 2.9 | -1.22 % | $ 10.8 M | USA |